New: Analysis of Union Budget 2026-27 impact on FTA Tariff Lines now live.View Update
Regional Focus

Gujarat Pharma Companies: Export APIs to EU with 0% Duty Under 2026 FTA

February 10, 20268 min readeufta.in

Quick Answer

Gujarat pharmaceutical companies can export APIs and formulations to EU with 0% duty (down from 11%) under 2026 FTA. Key requirement: Qualified Person (QP) batch release in Rotterdam. Monthly savings example: €2.64M on €2M API exports. Setup: 4-6 weeks for QP registration and EMA compliance.

Gujarat, particularly Ahmedabad and Sanand, is India's pharmaceutical manufacturing hub. With the 2026 EU-India FTA eliminating 11% duty on pharmaceutical exports, Gujarat-based companies can now compete more effectively in the European market of 450 million consumers.

Duty Elimination Impact

Pre-FTA (2025)

11% Duty

€2M export = €220K duty/month

Post-FTA (2026)

0% Duty

€2M export = €0 duty/month

Annual Savings: €2.64 million on €2M monthly exports

EMA Compliance: QP Batch Release

EU law requires every batch of medicinal products to be certified by a Qualified Person (QP) before release. This is mandatory under Annex 21 of EU GMP regulations.

Step 1: Batch Arrival

API or formulation arrives at Rotterdam warehouse. Batch documentation submitted to QP.

Step 2: Lab Testing

Samples tested in EU-accredited laboratory for identity, purity, and potency.

Step 3: QP Certification

EU-based Qualified Person reviews documentation and certifies batch release.

Step 4: Market Release

Certified batch released for distribution across EU marketplaces.

Gujarat Pharma Export Opportunities

Active Pharmaceutical Ingredients (APIs)

  • • Antibiotics and anti-infectives
  • • Cardiovascular APIs
  • • Central nervous system drugs
  • • Export value: $4.5B+ annually

Finished Formulations

  • • Generic medicines
  • • Over-the-counter products
  • • Ayurvedic formulations (with EFSA approval)
  • • Export value: $2B+ annually

GMP Site Audits

EU-GMP standards require regular site audits. eufta.in assists with:

  • Pre-inspection audits to identify compliance gaps
  • Documentation preparation for regulatory inspections
  • Remediation support for non-compliance issues
  • Ongoing compliance monitoring

Rotterdam Advantage for Gujarat Pharma

24-Hour Access to EU Markets

Fastest distribution to Germany, France, UK from Rotterdam

QP Services On-Site

EU-based Qualified Person available in Rotterdam for batch release

Temperature-Controlled Storage

GDP-compliant cold chain facilities for sensitive APIs

Article 23 VAT Deferment

Eliminate 21% upfront VAT payment, improve cash flow

Ready to Export from Gujarat?

Contact eufta.in for specialized pharma export support from Ahmedabad/Sanand to EU markets.

Get Pharma Export Guidance
E

eufta.in Trade Intelligence Team

LinkedIn

Trade analysts, customs brokers, and regulatory specialists at Sanjan Venture (Rotterdam, NL). Expertise in India-EU FTA tariff schedules, Article 23 VAT deferment, EFSA/EMA/REACH compliance, and EU marketplace logistics.

Published: February 10, 2026

Ready to Start Exporting?

Get personalized guidance for your export journey to the EU market.